The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset
Abstract
Type I diabetes may be an autoimmune disorder, although the evidence is largely circumstantial. The natural history of the disease after diagnosis includes partial remission in most patients, but only about 3 percent achieve transient insulin independence. β Cell function, as indicated by the plasma concentration of C-peptide, is lost over 6 to 30 months and islet cell antibodies disappeared over 1 to 2 years. This article describes a pilot study in which 41 patients were treated with the immunosuppressive agent cyclosporine for 2 to 12 months. Of 30 patients treated within 6 weeks of diagnosis, 16 became insulin independent with concentrations of plasma C-peptide in the normal range and decreasing titers of islet cell antibodies. Of 11 patients who entered the study 8 to 44 weeks after diagnosis, two achieved this state. These results indicate that a controlled trial of the effects of cyclosporine in type I diabetes should be conducted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Biological effects of cyclosporin A: A new antilymphocytic agent
Borel, J. F., Feurer, C., Gubler, H. U., & Stähelin, H. (1976) · Agents and Actions · doi:10.1007/bf01973261 · Cited by 1,509
Radioimmunological determination of human C-peptide in serum
Heding, L. G. (1975) · Diabetologia · doi:10.1007/bf01222104 · Cited by 830
Deckert, T., Poulsen, J. E., & Larsen, M. (1978) · Diabetologia · doi:10.1007/bf01228130 · Cited by 471
A CLICKING HIP IN A NEWBORN BABY SHOULD NEVER BE IGNORED
Cunningham, K. T., Beningfield, S., Moulton, A., & Maddock, C. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92180-9 · Cited by 387
Dorman, J. S., Laporte, R. E., Kuller, L. H., Cruickshanks, K. J., Orchard, T. J., Wagener, D. K., Becker, D. J., Cavender, D. E., & Drash, A. L. (1984) · Diabetes · doi:10.2337/diab.33.3.271 · Cited by 350
The pancreatic islets in diabetes
Gepts, W., & Lecompte, P. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90417-4 · Cited by 349
Franco Bottazzo, G. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91167-8 · Cited by 278
Insulin-Dependent Diabetes Mellitus: The Initial Lesion
Cahill, G. F., & McDevitt, H. O. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106113042403 · Cited by 272
Marliss, E. B., Nakhooda, A. F., Poussier, P., & Sima, A. A. F. (1982) · Diabetologia · doi:10.1007/bf00281296 · Cited by 247
Cited by
Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A
Handschumacher, R. E., Harding, M. W., Rice, J., Drugge, R. J., & Speicher, D. W. (1984) · Science · doi:10.1126/science.6238408 · Cited by 1,673
Eisenbarth (1986) · doi:10.1056/nejm198605223142106 · Cited by 1,659
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Cyclosporine-Associated Chronic Nephropathy
Myers, B. D., Ross, J., Newton, L., Luetscher, J., & Perlroth, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409133111103 · Cited by 1,144
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Herold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., Rother, K., Diamond, B., Harlan, D. M., & Bluestone, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1763 · Cited by 634
Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective
Zaccardi, F., Webb, D. R., Yates, T., & Davies, M. J. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133281 · Cited by 561
The long-term course of cyclosporine-associated chronic nephropathy
Myers, B. D., Sibley, R., Newton, L., Tomlanovich, S. J., Boshkos, C., Stinson, E., Luetscher, J. A., Whitney, D. J., Krasny, D., Coplon, N. S., et al. (1988) · Kidney International · doi:10.1038/ki.1988.38 · Cited by 506
The Murine Autoimmune Diabetes Model: NOD and Related Strains
Kikutani, H., & Makino, S. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60490-3 · Cited by 496
Faulds, D., Goa, K. L., & Benfield, P. (1993) · Drugs · doi:10.2165/00003495-199345060-00007 · Cited by 468
Feutren, G., Assan, R., Karsenty, G., Du Rostu, H., Sirmai, J., Papoz, L., Vialettes, B., Vexiau, P., Rodier, M., Lallemand, A., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91943-4 · Cited by 448
The Effects of Cyclosporin A on the Immune System
Shevach, E. (1985) · Annual Review of Immunology · doi:10.1146/annurev.immunol.3.1.397 · Cited by 443
Faulds, D., Goa, K. L., & Benfield, P. (1993) · Drugs · doi:10.1007/bf03259110 · Cited by 436
Cyclosporine-Induced Sympathetic Activation and Hypertension after Heart Transplantation
Scherrer, U., Vissing, S. F., Morgan, B. J., Rollins, J. A., Tindall, R. S. A., Ring, S., Hanson, P., Mohanty, P. K., & Victor, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009133231101 · Cited by 408
Factors Associated with Early Remission of Type I Diabetes in Children Treated with Cyclosporine
Bougneres, P. F., Carel, J. C., Castano, L., Boitard, C., Gardin, J. P., Landais, P., Hors, J., Mihatsch, M. J., Paillard, M., Chaussain, J. L., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803173181103 · Cited by 330
Myers, P. D. B. D. (1986) · Kidney International · doi:10.1038/ki.1986.280 · Cited by 325
Shah, S. C., Malone, J., & Simpson, N. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200902 · Cited by 317
Silverstein, J., Maclaren, N., Riley, W., Spillar, R., Radjenovic, D., & Johnson, S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809083191002 · Cited by 309
Natural Course of Insulin Resistance in Type I Diabetes
Yki-Järvinen, H., & Koivisto, V. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150404 · Cited by 304
A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal Transplantation
The Canadian Multicentre Transplant Study Group (1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141904 · Cited by 296
Isolation and amino acid sequence of cyclophilin.
Harding, M. W., Handschumacher, R. E., & Speicher, D. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83945-5 · Cited by 293
Guggenheimer, J., Moore, P. A., Rossie, K., Myers, D., Mongelluzzo, M. B., Block, H. M., Weyant, R., & Orchard, T. (2000) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1067/moe.2000.104477 · Cited by 281
100 years of insulin: celebrating the past, present and future of diabetes therapy
Sims, E. K., Carr, A. L. J., Oram, R. A., DiMeglio, L. A., & Evans-Molina, C. (2021) · Nature Medicine · doi:10.1038/s41591-021-01418-2 · Cited by 270
Organ‐Specific Autoimmunity: A 1986 Overview
Bottazzo, G. F., Todd, I., Mirakian, R., Belfiore, A., & Pujol‐Borrell, R. (1986) · Immunological Reviews · doi:10.1111/j.1600-065x.1986.tb01168.x · Cited by 267
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Rosenzwajg, M., Churlaud, G., Mallone, R., Six, A., Dérian, N., Chaara, W., Lorenzon, R., Long, S. A., Buckner, J. H., Afonso, G., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.01.001 · Cited by 257
Type 1 diabetes: translating mechanistic observations into effective clinical outcomes
Herold, K. C., Vignali, D. A. A., Cooke, A., & Bluestone, J. A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3422 · Cited by 237
T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins
Roep, B. O., Arden, S. D., de vries, R. R. P., & Hutton, J. C. (1990) · Nature · doi:10.1038/345632a0 · Cited by 185
Walter, M., Philotheou, A., Bonnici, F., Ziegler, A.-G., Jimenez, R., & on behalf of the NBI-6024 Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0449 · Cited by 119
“A treatment that could stop or reduce autoimmune destruction of pancreatic -cells would be a major advance in diabetes treatment and could potentially prevent diabetes in individuals genetically predisposed to developing the disease (4).”
BackgroundRecent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
Staeva, T. P., Chatenoud, L., Insel, R., & Atkinson, M. A. (2013) · Diabetes · doi:10.2337/db12-0562 · Cited by 91
Immune intervention in type 1 diabetes
Michels, A. W., & Eisenbarth, G. S. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.07.003 · Cited by 47
A historical view from thirty eventful years of immunotherapy in autoimmune diabetes
Bach, J.-F., & Chatenoud, L. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.07.009 · Cited by 41
Localization of Gingival Overgrowth in Heart Transplant Patients Undergoing Cyclosporin Therapy
Somacarrera, M. L., Hernández, G., Acero, J., & Moskow, B. S. (1994) · Journal of Periodontology · doi:10.1902/jop.1994.65.7.666 · Cited by 35
Persistence is the Twin Sister of Excellence
Greenbaum, C., & Atkinson, M. A. (2011) · Diabetes · doi:10.2337/db10-1810 · Cited by 17
Metadata
- Authors
- Stiller, C. R., Dupré, J., Gent, M., Jenner, M. R., Keown, P. A., Laupacis, A., Martell, R., Rodger, N. W., von Graffenried, B., & Wolfe, B. M. J.
- Venue
- Science
- Published
- 1984-03-30
- Volume
- 223
- Issue
- 4643
- Pages
- 1362-1367
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1986742496
- Cited by
- 556
- References
- 25
- FWCI
- 32.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.